CB vs IRD · P/E 14, rev $59.40B vs rev $11.0M
Chubb Ltd (CB) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CB and IRD stock pages for the full models.
Not investment advice.